HIV prevention involves several strategies designed to reduce the risk of acquiring human immunodeficiency virus. These strategies include using condoms, accessing HIV testing, avoiding the sharing of needles, and considering pre exposure prophylaxis, commonly known as PrEP. PrEP is a preventive medication for people who do not have HIV but may be exposed to the virus. When taken as prescribed,
HIV prevention is an important part of public health because it helps reduce new infections and supports early access to appropriate healthcare. Prevention methods can be selected according to individual circumstances, potential exposure, and medical guidance. PrEP has become an important option for people who may have an increased chance of exposure to HIV. However, it is not a treatment for existing HIV infection and does not prevent other sexually transmitted infections. Combining appropriate preventive measures with regular testing and professional healthcare guidance can support more effective HIV prevention.
Pre exposure prophylaxis, or PrEP, involves taking specific antiretroviral medications before potential exposure to HIV to reduce the likelihood of infection. These medicines interfere with the virus's ability to establish an infection in the body. PrEP is intended for people who are HIV negative and may benefit from additional protection based on their circumstances.
PrEP is available in different forms, including oral medication and long acting injections in countries where these options are approved and available. The appropriate option depends on local availability, medical eligibility, personal preferences, and clinical recommendations. HIV testing is necessary before starting PrEP because people with an existing HIV infection require a different treatment approach.
Important facts about PrEP and HIV prevention include:
Effectiveness: When taken as prescribed, PrEP is highly effective at preventing HIV acquired through sex. Oral PrEP also substantially reduces the risk associated with injection drug use when used consistently.
Eligibility: PrEP may be appropriate for people with HIV negative status who have sexual or injection-related circumstances associated with possible HIV exposure.
Medical assessment: Healthcare professionals assess HIV status, kidney function when relevant, other medications, and other health considerations before prescribing particular PrEP options.
Regular monitoring: Follow-up appointments and repeat HIV testing are important to confirm continued HIV negative status and monitor medication safety.
Other prevention methods: Condoms can reduce the risk of HIV and several other sexually transmitted infections, while sterile injection equipment helps prevent bloodborne infections.
PrEP does not protect against pregnancy or other sexually transmitted infections. Individuals should discuss suitable preventive measures with a qualified healthcare professional.
Using PrEP effectively involves more than obtaining medication. Individuals need an appropriate prescription, an HIV test before starting, and follow-up care according to the prescribed regimen. The schedule for monitoring and testing varies depending on whether oral or injectable PrEP is used and on individual medical circumstances.
People who think PrEP may be suitable can discuss their exposure risks and available options with a healthcare professional or an HIV prevention service. Access, approved medications, and eligibility requirements may differ by country and healthcare system.
Practical considerations for maintaining HIV prevention include:
Follow medical instructions: Take oral medication according to the prescribed schedule or attend appointments for scheduled injections.
Complete recommended tests: Regular HIV testing helps identify infection promptly and supports safe continuation of PrEP.
Discuss side effects: Some people experience temporary effects such as nausea or headaches. Persistent or concerning symptoms should be discussed with a healthcare professional.
Review missed doses: Protection can decrease when oral PrEP is not taken as directed. Seek professional advice about missed doses or interruptions rather than assuming protection continues.
Know about PEP: If a possible HIV exposure has occurred within the previous 72 hours, post exposure prophylaxis, or PEP, may be appropriate. It should be started as soon as possible after urgent medical assessment.
Continue comprehensive prevention: Condoms, testing for other sexually transmitted infections, and sterile injection equipment remain relevant where applicable.
PrEP is one component of a broader HIV prevention approach. People who already have HIV need appropriate antiretroviral treatment rather than PrEP alone. With accurate information, suitable medical guidance, and consistent follow-up, individuals can better understand their prevention options and make informed decisions about reducing HIV risk.